跳至主要内容
临床试验/NCT02575625
NCT02575625Unknown不适用

Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis

University Hospital, Tours1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2013年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
85
试验地点
1
主要终点
Viscosity in Pa.s

研究概览

简要总结

Hypothesis of this study is the existence of a relation between parameters measured by FibroScan® FS 502 according to our non invasive method and liver steatosis condition.

This proof of concept validation is made up of two steps:

  • Step 1: feasibility study of the method on 10 healthy volunteers
  • Step 2: diagnosis study on 50 healthy volunteers (25 between 18-30 years-old and 25 between 40-65 years-old) and on 25 patients whom cares including an liver biopsy et whom the histological answer is clean steatosis (NAFLD).

Experimental procedures consist in:

  • Fibroscan measure, preceded by tracking ultrasonography.
  • liver MRI (for substudy about MRI comparison, in step 2)
  • a blood test for biological assessment of liver functions

详细描述

Diagnosis of liver lipid overload (named liver steatosis), unrelated to alcohol consumption, still mainly based on histological exam of the liver. An histological continuity exists going from clean liver steatosis (Non Alcoholic Fatty Liver Disease, NAFLD) to steatohepatitis with signs of inflammation and tissue fibrosis (Non Alcoholic Steato-Hepatitis, NASH). It's now well-known that disease can evolve to cirrhosis and its complications.

Hypothesis of this study is the existence of a relation between parameters measured by FibroScan® FS 502 according to our non invasive method and liver steatosis condition.

This proof of concept validation is made up of two steps:

  • Step 1: feasibility study of the method on 10 healthy volunteers
  • Step 2: diagnosis study on 50 healthy volunteers (25 between 18-30 years-old and 25 between 40-65 years-old) and on 25 patients whom cares including an liver biopsy et whom the histological answer is clean steatosis (NAFLD).

Measures on healthy volunteers enable to do an intra-operator reproductibility analysis, a study of an age effect and a search of potential mechanic aging of the liver.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy subjects - Steps 1 and 2
  • •Age between 18 and 65 years old (2 age groups for step 2 : 18-30 et 40-65 years-old)
  • •Written inform consent form signed
  • •Affiliated to medical insurance
  • •Alcohol consumption d'alcool < 20g/j for women, <30g/j for men
  • •Patients with liver steatosis - Step 2
  • •More than 18 years -old
  • •Written inform consent form signed
  • •Affiliated to medical insurance
  • •Patients with clean steatosis confirmed by histological results of a liver biopsy done the previous month
  • •Alcohol consumption d'alcool < 20g/j for women, <30g/j for men

排除标准

  • •Healthy subjects - Step 1
  • •Exposure to chemical poisons (solvents, paints, drugs) in the previous 4 weeks
  • •Pregnant women, lactating women, and women in age for procreation and without reliable contraception
  • •Presence of ascites
  • •Person under guardianship
  • •Healthy subjects - Step 2
  • •Exposure to chemical poisons (solvents, paints, drugs) in the previous 4 weeks
  • •Pregnant women, lactating women, and women in age for procreation and without reliable contraception
  • •Contraindication to MRI
  • •Presence of ascites
  • •Person under guardianship
  • •Healthy subjects - Steps 1 and 2
  • •Presence of liver tumor or ascites (diagnosed with MRI or ultrasonography)
  • •Abnormal liver function tests (increase of transaminases, gammaGT)
  • •Patients with liver steatosis - Step 2
  • •Exposure to chemical poisons (solvents, paints, drugs) in the previous 4 weeks
  • •Pregnant women, lactating women, and women in age for procreation and without reliable contraception
  • •Contraindication to MRI
  • •Presence of ascites
  • •liver tumor
  • •Serology anti VHC+ or Ag HBs+
  • •Infection by HIV
  • •Auto-immun hepatitis
  • •Genetic hemochromatosis, Wilson disease, lake of alpha-1-antitrypsin
  • •Fibrosis or liver cirrhosis at biopsy
  • •Person under guardianship

研究组 & 干预措施

Fibroscan exam

Experimental

Step 1: feasibility study of the method on 10 healthy volunteers Step 2: diagnosis study on 50 healthy volunteers (25 between 18-30 years-old and 25 between 40-65 years-old) and on 25 patients whom cares including an hepatic biopsy et whom the histological answer is clean steatosis (NAFLD).

Experimental procedures consist in:

  • Fibroscan measure, preceded by tracking sonography.
  • liver MRI (for substudy about MRI comparison, in step 2)
  • a blood test for biological assessment of liver functions

干预措施: Fibroscan (Device)

Fibroscan exam

Experimental

Step 1: feasibility study of the method on 10 healthy volunteers Step 2: diagnosis study on 50 healthy volunteers (25 between 18-30 years-old and 25 between 40-65 years-old) and on 25 patients whom cares including an hepatic biopsy et whom the histological answer is clean steatosis (NAFLD).

Experimental procedures consist in:

  • Fibroscan measure, preceded by tracking sonography.
  • liver MRI (for substudy about MRI comparison, in step 2)
  • a blood test for biological assessment of liver functions

干预措施: Blood test for biological assessment of liver function (Biological)

Fibroscan exam

Experimental

Step 1: feasibility study of the method on 10 healthy volunteers Step 2: diagnosis study on 50 healthy volunteers (25 between 18-30 years-old and 25 between 40-65 years-old) and on 25 patients whom cares including an hepatic biopsy et whom the histological answer is clean steatosis (NAFLD).

Experimental procedures consist in:

  • Fibroscan measure, preceded by tracking sonography.
  • liver MRI (for substudy about MRI comparison, in step 2)
  • a blood test for biological assessment of liver functions

干预措施: MRI (Device)

结局指标

主要结局

Viscosity in Pa.s

时间窗: One day

Digital files recorded by medical device will be mathematically processed for extracting elasticity G' and viscosity G'' curves in accordance with the frequency. These curves use to identify the 5 parameters: mu(M), eta(M), alpha, mu(V), eta(V); which describe visco-elasticity variations with frequency thanks to an Matlab algorithm

Elasticity in kPa

时间窗: One day

Digital files recorded by medical device will be mathematically processed for extracting elasticity G' and viscosity G'' curves in accordance with the frequency. These curves use to identify the 5 parameters: mu(M), eta(M), alpha, mu(V), eta(V); which describe visco-elasticity variations with frequency thanks to an Matlab algorithm

次要结局

  • Reproductibility quantification in arbitrary unit(through study completion, an average of 2 years)
  • Age in years(through study completion, an average of 2 years)
  • Liver signal intensity changes in decibel(through study completion, an average of 2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验